Oncomfort announced the appointment of Karl Schweitzer as non-executive Director and Chairman of the Board.
Karl Schweitzer will take over from Tanja Dowe, CEO of Debiopharm Innovation Fund, who has led Oncomfort through the transformation into a scale-up-ready organisation and prepared the handover to domain-experienced board leadership,
Karl will not only bring his significant experience as business leader in medical device in the fields of neurology and cardiology, but also his multiple global leadership functions expertise in international companies and medtech startups.
Tanja Dowe explains:
I am excited to welcome Karl to take over the leadership of Oncomfort’s board. Strengthening the board was one of the key goals on our roadmap to global success – with Karl we have achieved this beyond expectations
Access to their full press release here